EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immune Mechanisms of Pulmonary Fibrosis with Bleomycin

Yuko Ishida, Yumi Kuninaka, Naofumi Mukaida, Toshikazu Kondo iD

International Journal of Molecular Sciences · 05.02.2023 · 24 (4) · 3149

DOI: 10.3390/ijms24043149 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.02.2023. Verfasst von Yuko Ishida und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Forensic Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-8509, Japan. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Lung Injury. Die Arbeit wurde bisher 122-mal zitiert (Crossref) und nennt 312 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grants-in-Aid for Scientific Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrosis and structural remodeling of the lung tissue can significantly impair lung function, often with fatal consequences. The etiology of pulmonary fibrosis (PF) is diverse and includes different triggers such as allergens, chemicals, radiation, and environmental particles. However, the cause of idiopathic PF (IPF), one of the most common forms of PF, remains unknown. Experimental models have been developed to study the mechanisms of PF, and the murine bleomycin (BLM) model has received the most attention. Epithelial injury, inflammation, epithelial–mesenchymal transition (EMT), myofibroblast activation, and repeated tissue injury are important initiators of fibrosis. In this review, we examined the common mechanisms of lung wound-healing responses after BLM-induced lung injury as well as the pathogenesis of the most common PF. A three-stage model of wound repair involving injury, inflammation, and repair is outlined. Dysregulation of one or more of these three phases has been reported in many cases of PF. We reviewed the literature investigating PF pathogenesis, and the role of cytokines, chemokines, growth factors, and matrix feeding in an animal model of BLM-induced PF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Pulmonary FibrosisLung InjuryMiceAnimalsBleomycinLungFibrosisInflammationEpithelial-Mesenchymal TransitionDisease Models, Animal

Stichwörter der Autor:innen

bleomycinchemokinescytokinesgrowth factorsidiopathic pulmonary fibrosisinflammationpulmonary fibrosiswound healing

Substanzen

Bleomycin

Autor:innen und Institutionen

  • Department of Forensic Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-8509, Japan.

ORCID-Profile: Toshikazu Kondo

Förderung

  • Grants-in-Aid for Scientific Research

Zitieren

APA

Ishida, Y., Kuninaka, Y., Mukaida, N., & Kondo, T. (2023). Immune Mechanisms of Pulmonary Fibrosis with Bleomycin. International Journal of Molecular Sciences, 24(4), 3149. https://doi.org/10.3390/ijms24043149

Vancouver

Ishida Y, Kuninaka Y, Mukaida N, Kondo T. Immune Mechanisms of Pulmonary Fibrosis with Bleomycin. International Journal of Molecular Sciences. 2023;24(4):3149. doi:10.3390/ijms24043149

BibTeX
@article{Ishida2023,
  author = {Ishida, Yuko and Kuninaka, Yumi and Mukaida, Naofumi and Kondo, Toshikazu},
  title = {Immune Mechanisms of Pulmonary Fibrosis with Bleomycin},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {4},
  pages = {3149},
  doi = {10.3390/ijms24043149}
}
Kostenlos starten →